Improvement of Gemcitabine-Based Therapy of Pancreatic Carcinoma by Means of Oncolytic Parvovirus H-1pv

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-08-1088
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

682: Synergistic Combination of Valproic Acid and Oncolytic Parvovirus H-1pv as a Potential Therapy Against Cervical and Pancreatic Carcinomas

European Journal of Cancer
Cancer ResearchOncology
2014English

Retargeting of Rat Parvovirus H-1pv to Cancer Cells Through Genetic Engineering of the Viral Capsid

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2012English

Silencing of B7-H3 Increases Gemcitabine Sensitivity by Promoting Apoptosis in Pancreatic Carcinoma

Oncology Letters
Cancer ResearchOncology
2013English

Preoperative Gemcitabine and Cisplatin Followed by Gemcitabine-Based Chemoradiation for Resectable Adenocarcinoma of the Pancreatic Head

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2008English

Verteporfin-Based Photodynamic Therapy Overcomes Gemcitabine Insensitivity in a Panel of Pancreatic Cancer Cell Lines

Lasers in Surgery and Medicine
DermatologySurgery
2011English

Predictors for Resectability and Survival in Locally Advanced Pancreatic Cancer After Gemcitabine-Based Neoadjuvant Therapy

Pancreatology
EndocrinologyHepatologyMetabolismGastroenterologyDiabetes
2016English

Atomic Resolution Structure of the Oncolytic Parvovirus LuIII by Electron Microscopy and 3D Image Reconstruction

Viruses
VirologyInfectious Diseases
2017English

Anti-Cancer Effects of Oncolytic Viral Therapy Combined With Photodynamic Therapy in Human Pancreatic Cancer Cell Lines

The Lancet
Medicine
2015English

A Novel Scalable, Robust Downstream Process for Oncolytic Rat Parvovirus: Isoelectric Point-Based Elimination of Empty Particles

Applied Microbiology and Biotechnology
Applied MicrobiologyBiotechnologyMedicine
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy